Latest Regulatory Milestones News

Page 1 of 102
Dominion Energy has passed a key US antitrust milestone in its proposed combination with NextEra Energy. The transaction is not yet cleared to close, with other regulatory approvals and closing conditions still outstanding.
Maxwell Dee
Maxwell Dee
21 Nov 2026
CurveBeam AI has received its first Chinese order for four HiRise weight-bearing CT systems from Weiying/Wego Orthopedics, turning regulatory clearance into an initial commercial foothold. The order value and delivery schedule were not disclosed, while a further A$1 million milestone investment is expected this quarter.
Victor Sage
Victor Sage
19 Nov 2026
Lake Resources says its Kachi lithium project in Argentina is now shovel-ready, with environmental approval secured, FEED underway and a revised Phase One plan showing lower capital costs. The harder test now is turning that progress into RIGI approval, financing, offtake agreements and a final investment decision.
Maxwell Dee
Maxwell Dee
19 Nov 2026
Nanosonics has secured a second US FDA 510(k) clearance for its CORIS System, expanding the range of colonoscopes and gastroscopes eligible for reprocessing. The regulatory milestone supports planned US launch activities, although the company has not disclosed a launch date or financial forecast.
Ada Torres
Ada Torres
11 Nov 2026
TMK Energy’s Gurvantes XXXV pilot delivered record October gas production as its two-rig work program got underway in Mongolia. The regulator has accepted the gas discovery declaration, but a Gas to Power investment decision has been pushed into 2027.
Maxwell Dee
Maxwell Dee
9 Nov 2026
Biotron CEO and executive director Glenn Gilbert has started more than two months ahead of schedule, immediately taking charge of a strategic review centred on SedRx. The review will also test development priorities, capital allocation and partnering options across the company’s drug portfolio.
Ada Torres
Ada Torres
9 Nov 2026
Axel REE has secured a State environmental licensing exemption and three-year water-use registration for its planned Woolrich in situ recovery field programme in Minas Gerais. The clearances allow testing to move from the laboratory into the field, although commercial production and project economics remain unestablished.
Maxwell Dee
Maxwell Dee
9 Nov 2026
Northern Star says commissioning at the expanded KCGM plant remains uneven, with October output below plan and production tracking towards the lower end of guidance. November performance has stabilised so far, while the Hemi project has cleared its primary environmental approvals.
Maxwell Dee
Maxwell Dee
9 Nov 2026
Solventum has raised its full-year adjusted earnings forecast after a third quarter shaped by the expected reversal of ERP-related advance orders. The healthcare technology company also completed its major system cutovers and reported strong growth in Advanced Wound Care.
Ada Torres
Ada Torres
6 Nov 2026
Rua Gold has submitted the substantive fast-track application for its proposed underground Auld Creek gold-antimony mine in New Zealand’s Reefton Goldfield. The milestone moves the project into statutory review, but it is not an approval and the company’s mid-2027 permitting target remains conditional.
Maxwell Dee
Maxwell Dee
6 Nov 2026
Edwards Lifesciences delivered stronger-than-expected third-quarter growth and lifted its full-year 2026 outlook, led by a sharp rise in mitral and tricuspid therapies. A US$220.2 million impairment charge remains a notable counterpoint to the upbeat operating performance.
Ada Torres
Ada Torres
5 Nov 2026
Taiko Critical Minerals widened its half-year loss to NZ$3.785 million as it advanced the Barrytown project, while raising NZ$9.5 million and lifting cash to NZ$7.8 million. The company now faces a December consent decision, an unconfirmed government funding offer and substantial convertible-note obligations.
Maxwell Dee
Maxwell Dee
5 Nov 2026

Browse the archive

Full archive